Buttorff Leslie's Form 4 filing
Panacea Life Sciences Holdings, Inc. (PLSH) · filed Apr 26, 2023
- Accession no.
- 0001493152-23-013730
- Filed
- Apr 26, 2023, 7:38 PM ET
- Trade date
- Apr 25-26, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market purchases total $3.84K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Buttorff LeslieCIK 0001866792 | Director, Officer (CEO), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 25, 2023 | Common Stock | PPurchaseAcquired | +1,000 | $0.32 | +$320 | 717,649 | Direct | |
| Apr 25, 2023 | Common Stock | PPurchaseAcquired | +3,500 | $0.3803 | +$1,331.05 | 721,149 | Direct | |
| Apr 26, 2023 | Common Stock | PPurchaseAcquired | +5,500 | $0.3976 | +$2,186.8 | 726,649 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.